Status:
COMPLETED
A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Breast Cancer
Metastatic Bone Disease
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
This is a 4-week study to examine the effects of a new experimental medication on women with breast cancer and established bone metastases. This study will enroll approximately 45 women. The primary h...
Eligibility Criteria
Inclusion
- Patient has histologically or cytologically-confirmed breast cancer
- Patient has documented skeletal metastases
Exclusion
- Patient is undergoing current oral bisphosphonate therapy, or has a history of oral bisphosphonate use within 6 months of entry into study
Key Trial Info
Start Date :
November 16 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 5 2007
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT00399802
Start Date
November 16 2006
End Date
December 5 2007
Last Update
August 16 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.